Effects of Liposuction and Exercise Training on Metabolism, Lipid Profile and Adiposity in Women
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 05508-900
- Escola de Educação Física e Esporte da Universidade de São Paulo
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 20 to 35-year old healthy subjects with a BMI of 22 to 28 Kg/m2;
- Non-smokers;
- Present stable body weight for 6 months (without variations exceeding 4 kg);
- Be in use contraceptive pill for at least 6 months;
Exclusion Criteria:
- Health problems that impede surgery or exercise training;
- Be in chronic use of antibiotics or antiinflammatory medication.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: exercise
exercise plus liposuction
|
combined resistance and aerobic training
|
|
No Intervention: sedentary
physical inactivity plus liposuction
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: 2 months post-intervention
|
Body composition will be assessed by hydrostatic weighing in order to measure fat and lean mass and by computer tomography, in order to measure abdominal total, subcutaneous and visceral fat areas and femoral and pelvic subcutaneous fat areas.
|
2 months post-intervention
|
|
Body composition
Time Frame: 6 months post-intervention
|
Body composition will be assessed by hydrostatic weighing in order to measure fat and lean mass and by computer tomography, in order to measure abdominal total, subcutaneous and visceral fat areas and femoral and pelvic subcutaneous fat areas.
|
6 months post-intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin Sensitivity
Time Frame: 2 months post-intervention
|
Insulin sensitivity will be assessed by an oral glucose tolerance test
|
2 months post-intervention
|
|
Total cholesterol, LDL-c, HDL-c, VLDL-c and triacylglycerol plasma levels
Time Frame: 2 months post-intervention
|
2 months post-intervention
|
|
|
Cytokine plasma levels - IL-6, TNF-alpha, IL-10, leptin and adiponectin levels
Time Frame: 2 months post-intervention
|
2 months post-intervention
|
|
|
Insulin Sensitivity
Time Frame: 6 months post-intervention
|
Insulin sensitivity will be assessed by an oral glucose tolerance test
|
6 months post-intervention
|
|
Total cholesterol, LDL-c, HDL-c, VLDL-c and triacylglycerol plasma levels
Time Frame: 6 months post-intervention
|
6 months post-intervention
|
|
|
Cytokine plasma levels - IL-6, TNF-alpha, IL-10, leptin and adiponectin levels
Time Frame: 6 months post-intervention
|
6 months post-intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Antonio H Lancha Jr, PhD, University of Sao Paulo
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- EEFEUSP-LIPO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.